ARTICLE | Clinical News
Tirosint levothyroxine: Postmarketing study started
August 18, 2014 7:00 AM UTC
Akrimax Pharmaceuticals LLC (Cranford, N.J.) began the open-label, U.S. postmarketing CONTROL trial to evaluate once-daily Tirosint in hypothyroid patients who have not previously achieved thyroid st...